Achievement Rates for Low-Density Lipoprotein Cholesterol Goals in Patients at High Risk of Atherosclerotic Cardiovascular Disease in a Real-World Setting in Japan
Author:
Affiliation:
1. Medical Affairs Division, Novartis Pharma K.K
2. Department of Cardiovascular Medicine, Kitasato University School of Medicine
3. Health Economics & Outcome Research, Creativ-Ceutical
4. Department of Cardiology, Rinku General Medical Center
Publisher
Japan Atherosclerosis Society
Subject
Biochemistry (medical),Cardiology and Cardiovascular Medicine,Internal Medicine
Link
https://www.jstage.jst.go.jp/article/jat/30/11/30_63940/_pdf
Reference32 articles.
1. 1) The Ministry of Health Labor and Welfare: Demographic statistics for Japan. 2018 Available from https: //www.mhlw.go.jp/toukei/saikin/hw/jinkou/geppo/nengai18/dl/gaikyou30.pdf; last accessed: August 2022. 2018
2. 2) Hirata K, Matsumoto K, Onishi R and Hasegawa T: Changing social burden of Japan’s three major diseases including Long-term Care due to aging. Public Administration and Policy, 2021; 24: 152-164
3. 3) Teramoto T: Is “The Japan Diet” Cardioprotective? J Atheroscler Thromb, 2017; 24: 388-389
4. 4) Sata M and Okamura T: Trends in the serum cholesterol level and dyslipidemia in Japan. Japanese Journal of Cardiovascular Disease Prevention, 2018; 53: 220-226
5. 5) Al-Shoaibi AAA, Li Y, Song Z, Chiang C, Hirakawa Y, Saif-Ur-Rahman KM, Shimoda M, Nakano Y, Matsunaga M, Aoyama A, Tamakoshi K, Ota A and Yatsuya H: Association of Low-Density Lipoprotein Cholesterol with Risk of Coronary Heart Disease and Stroke among Middle-Aged Japanese Workers: An Analysis using Inverse Probability Weighting. J Atheroscler Thromb, 2023; 30: 455-466
Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Efficacy, Safety, and Pharmacokinetics of Inclisiran in Japanese Patients: Results from ORION-15;Journal of Atherosclerosis and Thrombosis;2024
2. Residual cardiovascular risk, use of standard care treatments, and achievement of treatment goals in patients with cardiovascular disease;International Journal of Cardiology Cardiovascular Risk and Prevention;2023-09
3. Long-term Efficacy and Safety of K-924 Pitavastatin/Ezetimibe Fixed-dose Combination in Patients with Hypercholesterolemia: A Phase III, Multi-center, Open-label Trial;Journal of Atherosclerosis and Thrombosis;2023
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3